ICOS and T-cell non-Hodgkin lymphoma: When expressed in mice on a Tet2-/- background, the RHOAG17V mutation identified in 70% of AITL (99–101) results in T cell lymphomas that partially require ICOS and PI3K signaling for their proliferation and survival (102).